Cargando…
Monoclonal Antibodies in Cancer Therapy
Monoclonal antibody-based immunotherapy is now considered to be a main component of cancer therapy, alongside surgery, radiation, and chemotherapy. Monoclonal antibodies possess a diverse set of clinically relevant mechanisms of action. In addition, antibodies can directly target tumor cells while s...
Autores principales: | Zahavi, David, Weiner, Louis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551545/ https://www.ncbi.nlm.nih.gov/pubmed/32698317 http://dx.doi.org/10.3390/antib9030034 |
Ejemplares similares
-
Enhancing antibody-dependent cell-mediated cytotoxicity: a strategy for improving antibody-based immunotherapy
por: Zahavi, David, et al.
Publicado: (2018) -
Targeting Multiple Receptors to Increase Checkpoint Blockade Efficacy
por: Zahavi, David J., et al.
Publicado: (2019) -
Trial watch: Monoclonal antibodies in cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013) -
Mechanistic considerations for the use of monoclonal antibodies for cancer therapy
por: Glassman, Patrick M., et al.
Publicado: (2014) -
Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers
por: Hwang, Kyusang, et al.
Publicado: (2021)